{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:05:54Z","timestamp":1790690754662,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2019-107722RB-C21"],"award-info":[{"award-number":["PID2019-107722RB-C21"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016386","name":"Government of Valencia Ministry of Innovation Universities Science and Society","doi-asserted-by":"publisher","award":["CIPROM\/2021\/012"],"award-info":[{"award-number":["CIPROM\/2021\/012"]}],"id":[{"id":"10.13039\/501100016386","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computers in Biology and Medicine"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.compbiomed.2025.110447","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T03:50:16Z","timestamp":1749700216000},"page":"110447","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["In silico evaluation of pramlintide dosing algorithms in artificial pancreas systems"],"prefix":"10.1016","volume":"194","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-5014-0311","authenticated-orcid":false,"given":"Borja","family":"Pons Torres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6228-5190","authenticated-orcid":false,"given":"Iv\u00e1n","family":"Sala-Mira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2923-6618","authenticated-orcid":false,"given":"Clara","family":"Furi\u00f3-Novejarque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5659-1212","authenticated-orcid":false,"given":"Jos\u00e9-Luis","family":"D\u00edez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Bondia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.compbiomed.2025.110447_b1","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1152\/physrev.00025.2016","article-title":"The new biology and pharmacology of glucagon","volume":"97","author":"M\u00fcller","year":"2017","journal-title":"Physiol. Rev."},{"issue":"February","key":"10.1016\/j.compbiomed.2025.110447_b2","article-title":"Creating the amylin story","volume":"172","author":"Lutz","year":"2022","journal-title":"Appetite"},{"issue":"4","key":"10.1016\/j.compbiomed.2025.110447_b3","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/BF00400683","article-title":"Effect of 14 days\u2019 subcutaneous administration of the human amylin analogue, pramlintide (AC137), on an intravenous insulin challenge and response to a standard liquid meal in patients with IDDM","volume":"39","author":"Kolterman","year":"1996","journal-title":"Diabetologia"},{"issue":"12","key":"10.1016\/j.compbiomed.2025.110447_b4","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.2337\/dc07-2446","article-title":"Impaired hyperglycemia-induced delay in gastric emptying in patients with type 1 diabetes deficient for islet amyloid polypeptide","volume":"31","author":"Woerle","year":"2008","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.compbiomed.2025.110447_b5","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1210\/jc.2015-3952","article-title":"Effect of pramlintide on postprandial glucose fluxes in type 1 diabetes","volume":"101","author":"Hinshaw","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.compbiomed.2025.110447_b6","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1111\/dom.14447","article-title":"Alleviating carbohydrate counting with a FiASP-plus-pramlintide closed-loop delivery system (artificial pancreas): Feasibility and pilot studies","volume":"23","author":"Tsoukas","year":"2021","journal-title":"Diabetes Obes. Metab."},{"issue":"11","key":"10.1016\/j.compbiomed.2025.110447_b7","doi-asserted-by":"crossref","first-page":"e723","DOI":"10.1016\/S2589-7500(21)00139-4","article-title":"A fully artificial pancreas versus a hybrid artificial pancreas for type 1 diabetes: a single-centre, open-label, randomised controlled, crossover, non-inferiority trial","volume":"3","author":"Tsoukas","year":"2021","journal-title":"Lancet Digit. Heal."},{"issue":"9","key":"10.1016\/j.compbiomed.2025.110447_b8","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/aor.14023","article-title":"Dual-hormone artificial pancreas for management of type 1 diabetes: Recent progress and future directions","volume":"45","author":"Infante","year":"2021","journal-title":"Artif. Organs."},{"key":"10.1016\/j.compbiomed.2025.110447_b9","first-page":"1","article-title":"Dual-hormone insulin-and-pramlintide artificial pancreas for type 1 diabetes: A systematic review","volume":"12","author":"Torres-Casta\u00f1o","year":"2022","journal-title":"Appl. Sci. (Switzerland)"},{"issue":"3","key":"10.1016\/j.compbiomed.2025.110447_b10","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2337\/dc19-1922","article-title":"A novel dual-hormone insulin- and-pramlintide artificial pancreas for type 1 diabetes: A randomized controlled crossover trial","volume":"43","author":"Haidar","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.compbiomed.2025.110447_b11","doi-asserted-by":"crossref","first-page":"e489","DOI":"10.1016\/S2589-7500(24)00092-X","article-title":"Simple meal announcements and pramlintide delivery versus carbohydrate counting in type 1 diabetes with automated fast-acting insulin aspart delivery: a randomised crossover trial in Montreal, Canada","volume":"6","author":"Cohen","year":"2024","journal-title":"Lancet Digit. Heal."},{"key":"10.1016\/j.compbiomed.2025.110447_b12","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.2337\/dc12-0330","article-title":"Effect of pramlintide on prandial glycemic excursions during closed-loop control in adolescents and young adults with type 1 diabetes","volume":"35","author":"Weinzimer","year":"2012","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.compbiomed.2025.110447_b13","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1177\/1932296814542153","article-title":"Role of glucagon-like peptide-1 analogue versus amylin as an adjuvant therapy in type 1 diabetes in a closed loop setting with ePID algorithm","volume":"8","author":"Renukuntla","year":"2014","journal-title":"J. Diabetes Sci. Technol."},{"issue":"7","key":"10.1016\/j.compbiomed.2025.110447_b14","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.2337\/dc16-0089","article-title":"Mitigating meal-related glycemic excursions in an insulin-sparing manner during closed-loop insulin delivery: The beneficial effects of adjunctive pramlintide and liraglutide","volume":"39","author":"Sherr","year":"2016","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110447_b15","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/193229681000400117","article-title":"Simulation environment to evaluate closed-loop insulin delivery systems in type 1 diabetes","volume":"4","author":"Wilinska","year":"2010","journal-title":"J. Diabetes Sci. Technol."},{"key":"10.1016\/j.compbiomed.2025.110447_b16","doi-asserted-by":"crossref","DOI":"10.1109\/TBME.2017.2746340","article-title":"Type-1 diabetes patient decision simulator for in silico testing safety and effectiveness of insulin treatments","author":"Vettoretti","year":"2018","journal-title":"IEEE Trans. Biomed. Eng."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110447_b17","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/1932296813514502","article-title":"The UVA\/PADOVA type 1 diabetes simulator: New features","volume":"8","author":"Dalla Man","year":"2014","journal-title":"J. Diabetes Sci. Technol."},{"issue":"7","key":"10.1016\/j.compbiomed.2025.110447_b18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217301","article-title":"A statistical virtual patient population for the glucoregulatory system in type 1 diabetes with integrated exercise model","volume":"14","author":"Resalat","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110447_b19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1208\/s12248-012-9409-7","article-title":"Study reanalysis using a mechanism-based pharmacokinetic\/pharmacodynamic model of pramlintide in subjects with type 1 diabetes","volume":"15","author":"Fang","year":"2013","journal-title":"AAPS J."},{"issue":"3","key":"10.1016\/j.compbiomed.2025.110447_b20","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1177\/1932296813517323","article-title":"A model of glucose-insulin-pramlintide pharmacokinetics and pharmacodynamics in type I diabetes","volume":"8","author":"Ramkissoon","year":"2014","journal-title":"J. Diabetes Sci. Technol."},{"issue":"10","key":"10.1016\/j.compbiomed.2025.110447_b21","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1089\/dia.2013.0054","article-title":"In silico design of optimal ratio for co-administration of pramlintide and insulin in type 1 diabetes","volume":"15","author":"Micheletto","year":"2013","journal-title":"Diabetes Technol. Ther."},{"issue":"September 2023","key":"10.1016\/j.compbiomed.2025.110447_b22","article-title":"A model of subcutaneous pramlintide pharmacokinetics and its effect on gastric emptying: Proof-of-concept based on populational data","volume":"244","author":"Furi\u00f3-Novejarque","year":"2024","journal-title":"Comput. Methods Programs Biomed."},{"key":"10.1016\/j.compbiomed.2025.110447_b23","first-page":"7","article-title":"Optimal injection time of insulin to regulate postprandial glucose in type i diabetes in silico with pramlintide at meals","author":"Samaroo","year":"2018","journal-title":"Proc. UTT Res. Symp."},{"key":"10.1016\/j.compbiomed.2025.110447_b24","doi-asserted-by":"crossref","DOI":"10.1016\/j.isatra.2022.06.033","article-title":"Near-optimal feedback control for postprandial glucose regulation in type 1 diabetes","author":"Sanz","year":"2023","journal-title":"ISA Trans."},{"issue":"10","key":"10.1016\/j.compbiomed.2025.110447_b25","doi-asserted-by":"crossref","first-page":"4639","DOI":"10.1111\/dom.15827","article-title":"ADO09, a co-formulation of pramlintide and insulin A21g, lowers body weight versus insulin lispro in type 1 diabetes","volume":"26","author":"Andersen","year":"2024","journal-title":"Diabetes Obes. Metab."},{"issue":"12","key":"10.1016\/j.compbiomed.2025.110447_b26","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1109\/TBME.2006.883792","article-title":"A system model of oral glucose absorption: Validation on gold standard data","volume":"53","author":"Dalla Man","year":"2006","journal-title":"IEEE Trans. Biomed. Eng."},{"key":"10.1016\/j.compbiomed.2025.110447_b27","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.bbe.2024.08.003","article-title":"In silico validation of a customizable fully-autonomous artificial pancreas with coordinated insulin, glucagon and rescue carbohydrates","volume":"44","author":"Sanz","year":"2024","journal-title":"Biocybern. Biomed. Eng."},{"key":"10.1016\/j.compbiomed.2025.110447_b28","series-title":"Techniques of Model-Based Control","author":"Brosilow","year":"2002"},{"issue":"8","key":"10.1016\/j.compbiomed.2025.110447_b29","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.jcjd.2021.02.002","article-title":"Fully automated artificial pancreas for adults with type 1 diabetes using multiple hormones: Exploratory experiments","volume":"45","author":"Majdpour","year":"2021","journal-title":"Can. J. Diabetes"},{"issue":"3","key":"10.1016\/j.compbiomed.2025.110447_b30","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jpeds.2009.03.012","article-title":"Pramlintide lowered glucose excursions and was well-tolerated in adolescents with type 1 diabetes: Results from a randomized, single-blind, placebo-controlled, crossover study","volume":"155","author":"Chase","year":"2009","journal-title":"J. Pediatr."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110447_b31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/j.1552-4604.1996.tb04147.x","article-title":"Pharmacokinetics and pharmacodynamics of AC137 (25,28,29 tripro-amylin, human) after intravenous bolus and infusion doses in patients with insulin-dependent diabetes","volume":"36","author":"Colburn","year":"1996","journal-title":"J. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.compbiomed.2025.110447_b32","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s001250050949","article-title":"The effect of single doses of pramlintide on gastric emptying of two meals in men with IDDM","volume":"41","author":"Kong","year":"1998","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.compbiomed.2025.110447_b33","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.2337\/diabetes.54.4.1100","article-title":"The role of amylin and glucagon in the dampening of glycemic excursions in children with type 1 diabetes","volume":"54","author":"Heptulla","year":"2005","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.compbiomed.2025.110447_b34","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1046\/j.1464-5491.2002.00657_1.x","article-title":"Anti-diabetogenic effect of the human amylin analogue, pramlintide, in type 1 diabetes is not mediated by GLP-1","volume":"19","author":"Ahren","year":"2002","journal-title":"Diabetic Med."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110447_b35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1586\/17446651.2.1.9","article-title":"Pramlintide acetate in the treatment of type 2 and type 1 diabetes mellitus","volume":"2","author":"Edelman","year":"2007","journal-title":"Expert. Rev. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.compbiomed.2025.110447_b36","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1297\/cpe.24.153","article-title":"The factors affecting on estimation of carbohydrate content of meals in carbohydrate counting","volume":"24","author":"Kawamura","year":"2015","journal-title":"Clin. Pediatr. Endocrinol."},{"issue":"2","key":"10.1016\/j.compbiomed.2025.110447_b37","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1177\/1932296820952123","article-title":"Mathematical models of meal amount and timing variability with implementation in the type-1 diabetes patient decision simulator","volume":"15","author":"Camerlingo","year":"2021","journal-title":"J. Diabetes Sci. Technol."},{"issue":"8","key":"10.1016\/j.compbiomed.2025.110447_b38","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: Recommendations from the international consensus on time in range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.compbiomed.2025.110447_b39","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1177\/1932296819826111","article-title":"Glycemic variability: Risk factors, assessment, and control","volume":"13","author":"Kovatchev","year":"2019","journal-title":"J. Diabetes Sci. Technol."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110447_b40","doi-asserted-by":"crossref","DOI":"10.18637\/jss.v067.i01","article-title":"Fitting linear mixed-effects models using lme4","volume":"67","author":"Bates","year":"2015","journal-title":"J. Stat. Softw."},{"key":"10.1016\/j.compbiomed.2025.110447_b41","series-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2021"},{"issue":"9","key":"10.1016\/j.compbiomed.2025.110447_b42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v111.i09","article-title":"How to interpret statistical models using marginaleffects in R and Python","volume":"111","author":"Arel-Bundock","year":"2024","journal-title":"J. Stat. Softw."},{"issue":"7","key":"10.1016\/j.compbiomed.2025.110447_b43","doi-asserted-by":"crossref","first-page":"689","DOI":"10.4158\/EP09044.ORR1","article-title":"Continuous subcutaneous pramlintide infusion therapy in patients with type 1 diabetes: observations from a pilot study","volume":"15","author":"Huffman","year":"2009","journal-title":"Endocr. Pr. : Off. J. Am. Coll. Endocrinol. Am. Assoc. Clin. Endocrinol."},{"key":"10.1016\/j.compbiomed.2025.110447_b44","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1111\/dom.14972","article-title":"A co-formulation of pramlintide and insulin A21G (ADO09) improves postprandial glucose and short-term control of mean glucose, time in range, and body weight versus insulin aspart in adults with type 1 diabetes","volume":"25","author":"Andersen","year":"2023","journal-title":"Diabetes Obes. Metab."}],"container-title":["Computers in Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001048252500798X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001048252500798X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:13:23Z","timestamp":1790687603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001048252500798X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":44,"alternative-id":["S001048252500798X"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiomed.2025.110447","relation":{},"ISSN":["0010-4825"],"issn-type":[{"value":"0010-4825","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In silico evaluation of pramlintide dosing algorithms in artificial pancreas systems","name":"articletitle","label":"Article Title"},{"value":"Computers in Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiomed.2025.110447","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110447"}}